Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequence (Q46699153)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequence |
scientific article |
Statements
1 reference
Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequence (English)
1 reference
H Wildiers
1 reference
L Dirix
1 reference
P Neven
1 reference
A Prové
1 reference
P Clement
1 reference
P Squifflet
1 reference
F Amant
1 reference
T Skacel
1 reference
R Paridaens
1 reference
16 March 2008
1 reference
114
1 reference
1
1 reference
103-112
1 reference
Identifiers
1 reference